MYC amplification and high protein expression both independently and concurrently predict poor survival in pediatric and young adult osteosarcoma, beyond metastatic status. Incorporating MYC status into risk stratification may enhance prognostic accuracy and inform targeted therapeutic development.
No takes yet. Share an insight, caveat, or question.
Nagy et al. (2025) studied this question.
Synapse has enriched 5 related papers. Consider them for comparative context: